Someone who has a family member with multiple myeloma is at a slightly higher risk of developing the disease. Still, myeloma is not generally considered to be caused by family genetics. While some myeloma does exist in some families, the increase in risk could be caused by environmental or other factors. Genetic testing in families is not performed to detect myeloma or precursor conditions, especially for children.
Myeloma researchers at Dana Farber and Johns Hopkins are now performing the largest screening study in the history of myeloma to identify why family members and African Americans are more likely to develop the disease. The PROMISE study is inviting family members of MGUS, smoldering myeloma or multiple myeloma patients between the ages of 45-75 to donate blood samples. The study also includes all African Americans between the ages of 45 and 75. They will welcome 50,000 participants to donate blood so more can be learned about why precursor conditions develop into active myeloma. If you are African American or have family members with any of these conditions, please click the button below to register.
Someone who has a family member with multiple myeloma is at a slightly higher risk of developing the disease. Still, myeloma is not generally considered to be caused by family genetics. While some myeloma does exist in some families, the increase in risk could be caused by environmental or other factors. Genetic testing in families is not performed to detect myeloma or precursor conditions, especially for children.
Myeloma researchers at Dana Farber and Johns Hopkins are now performing the largest screening study in the history of myeloma to identify why family members and African Americans are more likely to develop the disease. The PROMISE study is inviting family members of MGUS, smoldering myeloma or multiple myeloma patients between the ages of 45-75 to donate blood samples. The study also includes all African Americans between the ages of 45 and 75. They will welcome 50,000 participants to donate blood so more can be learned about why precursor conditions develop into active myeloma. If you are African American or have family members with any of these conditions, please click the button below to register.
about the author
Jennifer Ahlstrom
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can contribute to cures by joining HealthTree Cure Hub and joining clinical research. Founder and CEO of HealthTree Foundation.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.